{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:32:23Z","timestamp":1777498343499,"version":"3.51.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS089851-01"],"award-info":[{"award-number":["1R21NS089851-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS071956-01A1"],"award-info":[{"award-number":["1R01NS071956-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"James and Esther King Biomedical Research Foundation","award":["1KG01-33966"],"award-info":[{"award-number":["1KG01-33966"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12975-015-0430-x","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T12:08:09Z","timestamp":1445342889000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke"],"prefix":"10.1007","volume":"6","author":[{"given":"Ike","family":"dela Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"issue":"3","key":"430_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2014.7692","volume":"312","author":"S Koton","year":"2014","unstructured":"Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259\u201368.","journal-title":"JAMA"},{"key":"430_CR2","volume-title":"World health report 2004-changing history","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. World health report 2004-changing history. Geneva: World Health Organization; 2004."},{"key":"430_CR3","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","volume":"371","author":"GA Donnan","year":"2008","unstructured":"Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612\u201323.","journal-title":"Lancet"},{"issue":"4","key":"430_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12975-014-0336-z","volume":"5","author":"S Hafez","year":"2014","unstructured":"Hafez S, Coucha M, Bruno A, Fagan SC, Ergul A. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl Stroke Res. 2014;5(4):442\u201353.","journal-title":"Transl Stroke Res"},{"key":"430_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrn1106","volume":"4","author":"EH Lo","year":"2003","unstructured":"Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Rev Neurosci. 2003;4:399\u2013415.","journal-title":"Nature Rev Neurosci"},{"key":"430_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Eng J Med. 2008;359:1317\u201329.","journal-title":"N Eng J Med"},{"key":"430_CR7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","volume":"28","author":"NINDS The","year":"2007","unstructured":"The NINDS, rt-PA Stroke Study Group (1997). Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. Stroke. 2007;28:2109\u201318.","journal-title":"Stroke"},{"issue":"16","key":"430_CR8","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.107.183689","volume":"116","author":"J Broderick","year":"2007","unstructured":"Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association\/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116(16):e391\u2013413.","journal-title":"Circulation"},{"key":"430_CR9","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1161\/01.STR.0000101752.23813.C3","volume":"34","author":"GD Graham","year":"2003","unstructured":"Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003;34:2847\u201350.","journal-title":"Stroke"},{"key":"430_CR10","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/STROKEAHA.106.479477","volume":"38","author":"TR Yip","year":"2007","unstructured":"Yip TR, Demaerschalk BM. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke. 2007;38:1952\u20135.","journal-title":"Stroke"},{"issue":"2","key":"430_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/brainsci3020599","volume":"3","author":"LL Stone","year":"2013","unstructured":"Stone LL, Grande A, Low WC. Neural repair and neuroprotection with stem cells in ischemic stroke. Brain Sci. 2013;3(2):599\u2013614.","journal-title":"Brain Sci"},{"issue":"5","key":"430_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1747-4949.2012.00840.x","volume":"7","author":"JD Sinden","year":"2012","unstructured":"Sinden JD, Muir KW. Stem cells in stroke treatment: the promise and the challenges. Int J Stroke. 2012;7(5):426\u201334.","journal-title":"Int J Stroke"},{"key":"430_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0149-7634(95)00063-1","volume":"21","author":"CV Borlongan","year":"1997","unstructured":"Borlongan CV, Koutouzis TK, Jorden JR, Martinez R, Rodriguez AI, Poulos SG, et al. Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci Biobehav Rev. 1997;21:79\u201390.","journal-title":"Neurosci Biobehav Rev"},{"key":"430_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0079-6123(00)27022-2","volume":"127","author":"H Nishino","year":"2000","unstructured":"Nishino H, Borlongan CV. Restoration of function by neural transplantation in the ischemic brain. Prog Brain Res. 2000;127:461\u201376.","journal-title":"Prog Brain Res"},{"issue":"4","key":"430_CR15","first-page":"12912","volume":"4","author":"K Shinozuka","year":"2013","unstructured":"Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kim DW, Pabon M, et al. Stem cells for neurovascular repair in stroke. J Stem Cell Res Ther. 2013;4(4):12912.","journal-title":"J Stem Cell Res Ther"},{"key":"430_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/brainsci3010239","volume":"3","author":"K Shinozuka","year":"2013","unstructured":"Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, et al. Stem cell transplantation for neuroprotection in stroke. Brain Sci. 2013;3:239\u201361.","journal-title":"Brain Sci"},{"key":"430_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3727\/096368911X627417","volume":"21","author":"X Cui","year":"2012","unstructured":"Cui X, Chopp M, Shehadah A, Zacharek A, Kuzmin-Nichols N, Sanberg D, et al. Therapeutic benefit of treatment of stroke with simvastin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth. Cell Transplant. 2012;21:845\u201356.","journal-title":"Cell Transplant"},{"key":"430_CR18","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1074\/jbc.M111.296434","volume":"287","author":"D Rowe","year":"2012","unstructured":"Rowe D, Leonardo C, Recio J, Collier L, Willing A, Pennypacker K. Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. J Biol Chem. 2012;287:4177\u201387.","journal-title":"J Biol Chem"},{"key":"430_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/scd.2005.14.722","volume":"14","author":"J Xiao","year":"2005","unstructured":"Xiao J, Nan Z, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev. 2005;14:722\u201333.","journal-title":"Stem Cells Dev"},{"key":"430_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/B978-0-444-59544-7.00006-8","volume":"201","author":"PR Sanberg","year":"2012","unstructured":"Sanberg PR, Eve DJ, Metcalf C, Borlongan CV. Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke. Prog Brain Res. 2012;201:99\u2013117.","journal-title":"Prog Brain Res"},{"issue":"Suppl 4","key":"430_CR21","first-page":"S4","volume":"1","author":"SA Acosta","year":"2013","unstructured":"Acosta SA, Franzese N, Staples M, Weinbren NL, Babilonia M, Patel J, et al. Human umbilical cord for transplantation therapy in myocardial infarction. J Stem Cell Res Ther. 2013;1 Suppl 4:S4\u2013005.","journal-title":"J Stem Cell Res Ther"},{"key":"430_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1196\/annals.1334.008","volume":"1049","author":"PR Sanberg","year":"2005","unstructured":"Sanberg PR, Willing AE, Garbuzova-Davis S, Saporta S, Liu G, Sanberg CD, et al. Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci. 2005;1049:67\u201383.","journal-title":"Ann N Y Acad Sci"},{"key":"430_CR23","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/jnr.22162","volume":"87","author":"DJ Chung","year":"2009","unstructured":"Chung DJ, Choi CB, Lee SH, Kang EH, Lee JH, Hwang SH, et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res. 2009;87:3554\u201367.","journal-title":"J Neurosci Res"},{"issue":"4","key":"430_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.7861\/clinmedicine.9-4-342","volume":"9","author":"N Copeland","year":"2009","unstructured":"Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med. 2009;9(4):342\u20135.","journal-title":"Clin Med"},{"key":"430_CR25","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1161\/01.STR.0000141681.06735.9b","volume":"35","author":"M Vendrame","year":"2004","unstructured":"Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004;35:2390\u20135.","journal-title":"Stroke"},{"key":"430_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/jnr.10659","volume":"73","author":"AE Willing","year":"2003","unstructured":"Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296\u2013307.","journal-title":"J Neurosci Res"},{"key":"430_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/bmb\/lds008","volume":"102","author":"D Ilic","year":"2012","unstructured":"Ilic D, Miere C, Lazic E. Umbilical cord blood cells: clinical trials in non-hematological disorders. Brit Med Bull. 2012;102:43\u201357.","journal-title":"Brit Med Bull"},{"issue":"1","key":"430_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.expneurol.2006.04.001","volume":"199","author":"MB Newman","year":"2006","unstructured":"Newman MB, Willing AE, Manresa JJ, Sanberg CD, Sanberg PR. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol. 2006;199(1):201\u20138.","journal-title":"Exp Neurol"},{"issue":"1","key":"430_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1179\/1743132814Y.0000000399","volume":"37","author":"J Ma","year":"2015","unstructured":"Ma J, Liu N, Yi B, Zhang X, Gao BB, Zhang Y, et al. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1\/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats. Neurol Res. 2015;37(1):50\u20136.","journal-title":"Neurol Res"},{"issue":"3","key":"430_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3727\/096020198389924","volume":"11","author":"D Lu","year":"2002","unstructured":"Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002;11(3):275\u201381.","journal-title":"Cell Transplant"},{"issue":"2","key":"430_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/01.WCB.0000111614.19196.04","volume":"24","author":"HM Bramlett","year":"2004","unstructured":"Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab. 2004;24(2):133\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"430_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3727\/096368911X586783","volume":"21","author":"J Boltze","year":"2012","unstructured":"Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, Lobsien D, et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant. 2012;21(4):723\u201337.","journal-title":"Cell Transplant"},{"issue":"6","key":"430_CR33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/scd.2008.0023","volume":"17","author":"RJ Henning","year":"2008","unstructured":"Henning RJ, Shariff M, Eadula U, Alvarado F, Vasko M, Sanberg PR, et al. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem Cells Dev. 2008;17(6):1207\u201319.","journal-title":"Stem Cells Dev"},{"key":"430_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/pr.2011.59","volume":"71","author":"PM Pimentel-Coelho","year":"2012","unstructured":"Pimentel-Coelho PM, Rosado-de Castro PH, da Fonseca LM B, Otero RM. Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy. Pediatr Res. 2012;71:464\u201373.","journal-title":"Pediatr Res"},{"issue":"3","key":"430_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3727\/096368915X686913","volume":"24","author":"I dela Pe\u00f1a","year":"2015","unstructured":"dela Pe\u00f1a I, Sanberg PR, Acosta S, Lin SZ, Borlongan CV. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplant. 2015;24(3):447\u201357.","journal-title":"Cell Transplant"},{"issue":"4","key":"430_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2217\/rme.14.32","volume":"9","author":"I dela Pe\u00f1a","year":"2014","unstructured":"dela Pe\u00f1a I, Sanberg PR, Acosta S, Lin SZ, Borlongan CV. Umbilical cord blood cell and granulocyte-colony stimulating factor: combination therapy for traumatic brain injury. Regen Med. 2014;9(4):409\u201312.","journal-title":"Regen Med"},{"issue":"3","key":"430_CR37","first-page":"145","volume":"58","author":"I dela Pe\u00f1a","year":"2014","unstructured":"dela Pe\u00f1a I, Sanberg PR, Acosta S, Tajiri N, Lin SZ, Borlongan CV. Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor. J Neurosurg Sci. 2014;58(3):145\u20139.","journal-title":"J Neurosurg Sci"},{"issue":"11","key":"430_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/3473","volume":"16","author":"JD Flax","year":"1998","unstructured":"Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol. 1998;16(11):1033\u20139.","journal-title":"Nat Biotechnol"},{"key":"430_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3727\/096368909788237122","volume":"18","author":"R Matsuda","year":"2009","unstructured":"Matsuda R, Yoshikawa M, Kimura H, Ouji Y, Nakase H, Nishimura F, et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transpl. 2009;18:39\u201354.","journal-title":"Cell Transpl"},{"key":"430_CR40","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/stem.161","volume":"27","author":"N Nakagomi","year":"2009","unstructured":"Nakagomi N, Nakagomi T, Kubo S, Nakano-Doi A, Saino O, Takata M, et al. Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem\/progenitor cells after cerebral infarction. Stem Cells. 2009;27:2185\u201395.","journal-title":"Stem Cells"},{"key":"430_CR41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.brainres.2010.08.072","volume":"1359","author":"W Zhang","year":"2010","unstructured":"Zhang W, Yan Q, Zeng YS, Zhang XB, Xiong Y, Wang JM, et al. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 2010;1359:256\u201371.","journal-title":"Brain Res"},{"key":"430_CR42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/jcbfm.2009.219","volume":"30","author":"K Jin","year":"2010","unstructured":"Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y, et al. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab. 2010;30:534\u201344.","journal-title":"J Cereb Blood Flow Metab"},{"key":"430_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2843","volume":"10","author":"D Metcalf","year":"2010","unstructured":"Metcalf D. The colony-stimulating factors and cancer. Nat Rev Cancer. 2010;10:425\u201334.","journal-title":"Nat Rev Cancer"},{"key":"430_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-0348-0218-5_2","volume-title":"Twenty years of G-CSF, milestones in drug therapy","author":"K Welte","year":"2012","unstructured":"Welte K. Discovery of G-CSF and early clinical studies. In: Molineux G et al., editors. Twenty years of G-CSF, milestones in drug therapy. Basel: Springer Basel AG; 2012. p. 15\u201324."},{"key":"430_CR45","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1084\/jem.162.6.1788","volume":"162","author":"E Platzer","year":"1985","unstructured":"Platzer E, Welte K, Gabrilove JL, Lu L, Harris P, Mertelsmann R, et al. Biological activities of a human pluripotent hematopoietic colony stimulating factor on normal and leukemic cells. J Exp Med. 1985;162:1788\u2013801.","journal-title":"J Exp Med"},{"key":"430_CR46","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.4161\/cc.4.12.2213","volume":"4","author":"A Schneider","year":"2005","unstructured":"Schneider A, Kuhn HG, Schabitz WR. A role for G-CSF (granulocyte colony stimulating factor) in the central nervous system. Cell Cycle. 2005;4:1753\u20137.","journal-title":"Cell Cycle"},{"issue":"37","key":"430_CR47","doi-asserted-by":"publisher","first-page":"11572","DOI":"10.1523\/JNEUROSCI.0453-09.2009","volume":"29","author":"K Diederich","year":"2009","unstructured":"Diederich K, Sevimli S, D\u00f6rr H, K\u00f6sters E, Hoppen M, Lewejohann L, et al. The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain. A characterization of G-CSF-deficient mice. J Neurosci. 2009;29(37):11572\u201381.","journal-title":"J Neurosci"},{"key":"430_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2040-7378-1-2","volume":"1","author":"J Minnerup","year":"2009","unstructured":"Minnerup J, Sevimli S, Schabitz WR. Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med. 2009;1:2.","journal-title":"Exp Transl Stroke Med"},{"issue":"6","key":"430_CR49","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/j.1582-4934.2007.00101.x","volume":"11","author":"X Bao-Guo","year":"2007","unstructured":"Bao-Guo X. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection. J Cell Mol Med. 2007;11(6):1272\u201390.","journal-title":"J Cell Mol Med"},{"key":"430_CR50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/01.STR.0000057814.70180.17","volume":"34","author":"WR Schabitz","year":"2003","unstructured":"Schabitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN, et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke. 2003;34:745\u201351.","journal-title":"Stroke"},{"key":"430_CR51","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1172\/JCI23559","volume":"115","author":"A Schneider","year":"2005","unstructured":"Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115:2083\u201398.","journal-title":"J Clin Invest"},{"key":"430_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/sj.jcbfm.9600195","volume":"26","author":"M Komine-Kobayashi","year":"2006","unstructured":"Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, Osaka A, et al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab. 2006;26:402\u201313.","journal-title":"J Cereb Blood Flow Metab"},{"key":"430_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2007.07.056","volume":"432","author":"JL Han","year":"2008","unstructured":"Han JL, Blank T, Schwab S, Kollmar R. Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke. Neurosci Lett. 2008;432:167\u20139.","journal-title":"Neurosci Lett"},{"key":"430_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.neuroscience.2006.09.014","volume":"143","author":"I Solaroglu","year":"2006","unstructured":"Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience. 2006;143:965\u201374.","journal-title":"Neuroscience"},{"issue":"2","key":"430_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1179\/174313209X393582","volume":"31","author":"I Solaroglu","year":"2009","unstructured":"Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH. Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res. 2009;31(2):167\u201372.","journal-title":"Neurol Res"},{"key":"430_CR56","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/01.CIR.0000142616.07367.66","volume":"110","author":"WC Shyu","year":"2004","unstructured":"Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation. 2004;110:1847\u201354.","journal-title":"Circulation"},{"key":"430_CR57","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","volume":"35","author":"X Wang","year":"2004","unstructured":"Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35:2726\u201330.","journal-title":"Stroke"},{"issue":"2","key":"430_CR58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/jcbfm.2014.208","volume":"35","author":"IC dela Pe\u00f1a","year":"2015","unstructured":"dela Pe\u00f1a IC, Yoo A, Tajiri N, Acosta SA, Ji X, Kaneko Y, et al. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab. 2015;35(2):338\u201346.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"430_CR59","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1161\/STROKEAHA.113.001943","volume":"4","author":"H Ishikawa","year":"2013","unstructured":"Ishikawa H, Tajiri N, Shinozuka K, Vasconcellos J, Kaneko Y, Lee HJ, et al. Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke. 2013;4(12):3473\u201381.","journal-title":"Stroke"},{"issue":"25","key":"430_CR60","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2174\/138161212802002733","volume":"18","author":"Y Kaneko","year":"2012","unstructured":"Kaneko Y, Tajiri N, Shinozuka K, Glover LE, Weinbren NL, Cortes L, et al. Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des. 2012;18(25):3731\u20134.","journal-title":"Curr Pharm Des"},{"key":"430_CR61","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/01.STR.0000248763.49831.c3","volume":"37","author":"N Sprigg","year":"2006","unstructured":"Sprigg N, Bath PM, Zhao L, Willmot MR, Gray LJ, Walker MF, et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery Enhancement After Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke. 2006;37:2979\u201383.","journal-title":"Stroke"},{"key":"430_CR62","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1503\/cmaj.051322","volume":"174","author":"WC Shyu","year":"2006","unstructured":"Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ. 2006;174:927\u201333.","journal-title":"CMAJ"},{"key":"430_CR63","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/STROKEAHA.110.579508","volume":"41","author":"WR Schabitz","year":"2010","unstructured":"Schabitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, et al. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke. 2010;41:2545\u201351.","journal-title":"Stroke"},{"issue":"10","key":"430_CR64","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1161\/STROKEAHA.113.001531","volume":"44","author":"EB Ringelstein","year":"2013","unstructured":"Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, et al. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke. 2013;44(10):2681\u20137.","journal-title":"Stroke"},{"key":"430_CR65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pneurobio.2013.12.002","volume":"115","author":"C An","year":"2014","unstructured":"An C, Shi Y, Li P, Hu X, Gan Y, Stetler RA, et al. Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol. 2014;115:6\u201324.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"430_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12975-012-0209-2","volume":"4","author":"PA Lapchak","year":"2013","unstructured":"Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res. 2013;4(3):279\u201385.","journal-title":"Transl Stroke Res"},{"issue":"15","key":"430_CR67","first-page":"00005","volume":"S0014\u20134886","author":"L Li","year":"2015","unstructured":"Li L, McBride DW, Doycheva D, Dixon BJ, Krafft PR, Zhang JH, et al. G-CSF attenuates neuroinflammation and stabilizes the blood\u2013brain barrier via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway following neonatal hypoxia-ischemia in rats. Exp Neurol. 2015;S0014\u20134886(15):00005\u20139.","journal-title":"Exp Neurol"},{"issue":"7","key":"430_CR68","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1538-7836.2010.03897.x","volume":"8","author":"T Sobrino","year":"2010","unstructured":"Sobrino T, Mill\u00e1n M, Castellanos M, Blanco M, Brea D, Dorado L, et al. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA. J Thromb Haemost. 2010;8(7):1567\u201374.","journal-title":"J Thromb Haemost"},{"key":"430_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2013.11.007","volume":"115","author":"X Liu","year":"2014","unstructured":"Liu X, Ye R, Yan T, Yu SP, Wei L, Xu G, et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol. 2014;115:92\u2013115.","journal-title":"Prog Neurobiol"},{"key":"430_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2202-12-61","volume":"12","author":"XM Zhang","year":"2011","unstructured":"Zhang XM, Du F, Yang D, Wang R, Yu C, Huang XN, et al. Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice. BMC Neurosci. 2011;12:61.","journal-title":"BMC Neurosci"},{"key":"430_CR71","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fnagi.2014.00130","volume":"6","author":"AT Balseanu","year":"2014","unstructured":"Balseanu AT, Buga AM, Catalin B, Wagner DC, Boltze J, Zagrean AM, et al. Multimodal approaches for regenerative stroke therapies: combination of granulocyte colony-stimulating factor with bone marrow mesenchymal stem cells is not superior to G-CSF alone. Front Aging Neurosci. 2014;6:130.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"430_CR72","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/STROKEAHA.109.575621","volume":"41","author":"A Popa-Wagner","year":"2010","unstructured":"Popa-Wagner A, St\u00f6cker K, Balseanu AT, Rogalewski A, Diederich K, Minnerup J, et al. Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke. 2010;41(5):1027\u201331.","journal-title":"Stroke"},{"issue":"9(3","key":"430_CR73","doi-asserted-by":"publisher","first-page":"e90953","DOI":"10.1371\/journal.pone.0090953","volume":"12","author":"SA Acosta","year":"2014","unstructured":"Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, et al. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One. 2014;12(9(3):e90953.","journal-title":"PLoS One"},{"key":"430_CR74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.5966\/sctm.2013-0066","volume":"2","author":"A Iskander","year":"2013","unstructured":"Iskander A, Knight RA, Zhang ZG, Ewing JR, Shankar A, Varma NR, et al. Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings. Stem Cells Transl Med. 2013;2:703\u201314.","journal-title":"Stem Cells Transl Med"},{"key":"430_CR75","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s11357-012-9496-5","volume":"35","author":"M Shahaduzzaman","year":"2013","unstructured":"Shahaduzzaman M, Golden JE, Green S, Gronda AE, Adrien E, Ahmed A, et al. A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus. Age (Dordr). 2013;35:2071\u201387.","journal-title":"Age (Dordr)"},{"issue":"1","key":"430_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1574889811308010002","volume":"8","author":"LR Zhao","year":"2013","unstructured":"Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME. The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke. Recent Pat CNS Drug Discov. 2013;8(1):2\u201312.","journal-title":"Recent Pat CNS Drug Discov"},{"key":"430_CR77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroscience.2009.05.071","volume":"163","author":"J Sanchez-Ramos","year":"2009","unstructured":"Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, et al. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer\u2019s mice. Neuroscience. 2009;163:55\u201372.","journal-title":"Neuroscience"},{"key":"430_CR78","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1182\/blood-2007-10-119073","volume":"111","author":"ZE Toth","year":"2008","unstructured":"Toth ZE, Leker RR, Shahar T, Pastorino S, Szalayova I, Asemenew B, et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood. 2008;111:5544\u201352.","journal-title":"Blood"},{"key":"430_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/STROKEAHA.111.636449","volume":"43","author":"TJ England","year":"2012","unstructured":"England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke. 2012;43:405\u201311.","journal-title":"Stroke"},{"issue":"24","key":"430_CR80","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2012-12-475392","volume":"122","author":"DL Stachura","year":"2013","unstructured":"Stachura DL, Svoboda O, Campbell CA, Esp\u00edn-Palaz\u00f3n R, Lau RP, Zon LI, et al. The zebrafish granulocyte colony stimulating factors (Gcsfs): two paralogous cytokines and their roles in hematopoietic development and maintenance. Blood. 2013;122(24):3918\u201328.","journal-title":"Blood"},{"issue":"3","key":"430_CR81","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/08977199909002132","volume":"16","author":"T Tsuji","year":"1999","unstructured":"Tsuji T, Nishimura-Morita Y, Watanabe Y, Hirano D, Nakanishi S, Mori KJ, et al. A murine stromal cell line promotes the expansion of CD34high+-primitive progenitor cells isolated from human umbilical cord blood in combination with human cytokines. Growth Factors. 1999;16(3):225\u201340.","journal-title":"Growth Factors"},{"key":"430_CR82","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/leu.2011.167","volume":"25","author":"CV Borlongan","year":"2011","unstructured":"Borlongan CV. Bone marrow stem cell mobilization in stroke: a \u2018bonehead\u2019 may be good after all! Leukemia. 2011;25:1674\u201386.","journal-title":"Leukemia"},{"issue":"10","key":"430_CR83","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1179\/016164110X12807570510013","volume":"32","author":"DY Yang","year":"2010","unstructured":"Yang DY, Chen YJ, Wang MF, Pan HC, Chen SY, Cheng FC. Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury. Neurol Res. 2010;32(10):1041\u20139.","journal-title":"Neurol Res"},{"key":"430_CR84","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3727\/096368910X503415","volume":"19","author":"M Yang","year":"2010","unstructured":"Yang M, Wei X, Li J, Heine LA, Rosenwasser R, Iacovitti L. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats. Cell Transplant. 2010;19:1073\u201384.","journal-title":"Cell Transplant"},{"key":"430_CR85","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.neulet.2005.01.070","volume":"380","author":"CG Fan","year":"2005","unstructured":"Fan CG, Zhang QJ, Tang FW, Han ZB, Wang GS, Han ZC. Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett. 2005;380:322\u20135.","journal-title":"Neurosci Lett"},{"issue":"2","key":"430_CR86","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/jnc.12120","volume":"125","author":"K Hayakawa","year":"2013","unstructured":"Hayakawa K, Miyamoto N, Seo JH, Pham LD, Kim KW, Lo EH, et al. High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. J Neurochem. 2013;125(2):273\u201380.","journal-title":"J Neurochem"},{"key":"430_CR87","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3727\/000000003108746885","volume":"12","author":"AE Willing","year":"2003","unstructured":"Willing AE, Vendrame M, Mallery J, Cassady CJ, Davis CD, Sanchez-Ramos J, et al. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 2003;12:449\u201354.","journal-title":"Cell Transplant"},{"issue":"7","key":"430_CR88","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1517\/14712598.2015.1043264","volume":"15","author":"R Sullivan","year":"2015","unstructured":"Sullivan R, Duncan K, Dailey T, Kaneko Y, Tajiri N, Borlongan CV. A possible new focus for stroke treatment\u2013migrating stem cells. Expert Opin Biol Ther. 2015;15(7):949\u201358.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"430_CR89","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/jcm2040220","volume":"2","author":"T Dailey","year":"2013","unstructured":"Dailey T, Metcalf C, Mosley YI, Sullivan R, Shinozuka K, Tajiri N, et al. An update on translating stem cell therapy for stroke from bench to bedside. J Clin Med. 2013;2(4):220\u201341.","journal-title":"J Clin Med"},{"key":"430_CR90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/bmb\/lds001","volume":"101","author":"PR Sanberg","year":"2012","unstructured":"Sanberg PR, Eve DJ, Cruz LE, Borlongan CV. Neurological disorders and the potential role for stem cells as a therapy. Br Med Bull. 2012;101:163\u201381.","journal-title":"Br Med Bull"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-015-0430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-015-0430-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-015-0430-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-015-0430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:39:42Z","timestamp":1589737182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-015-0430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s12975-015-0430-x","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]},"assertion":[{"value":"18 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This article does not contain studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study was supported, in part, by the National Institutes of Health National Institute of Neurological Disorders and Stroke 1R01NS071956-01A1, 1R21NS089851-01, James and Esther King Biomedical Research Foundation 1KG01-33966, and Loma Linda University School of Pharmacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"C. V. Borlongan has patents and patent applications on stem cell therapy. I. dela Pe\u00f1a declares that he has no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}